Skip to content

Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use

The Effect of Systane® Compared to Marketed Artificial Tears on Frequency of Drop Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00347984
Enrollment
50
Registered
2006-07-04
Start date
2005-12-31
Completion date
2006-02-28
Last updated
2012-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Brief summary

The objective of this study was to evaluate the effect of Systane® compared to marketed artificial tears on the frequency of drop use.

Interventions

Sponsors

ORA, Inc.
CollaboratorINDUSTRY
Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects age 18 (minimum); reported history of dry eye syndrome in both eyes; TFBUT ≤ 7 seconds in at least 1 eye at Visit 1; ≥ 1+ fluorescein staining score in any region in at least 1 eye at Visit 1; desire to use an artificial tear substitute for dry eye symptoms at least 4 times per day at Visit 1 and Visit 2.

Exclusion criteria

* Age less than 18 years

Design outcomes

Primary

MeasureTime frame
Frequency of drop use and/or desire to use; Drop preference

Secondary

MeasureTime frame
Product questionnaire; Symptoms; Corneal and conjunctival staining; Tear film break-up time (TFBUT).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026